- Home
- IMTX vs CII Comparison
IMTX vs CII Comparison
Compare IMTX & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- CII
- Stock Information
- Founded
- IMTX N/A
- CII 2004
- Country
- IMTX Germany
- CII United States
- Employees
- IMTX N/A
- CII N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- CII Investment Bankers/Brokers/Service
- Sector
- IMTX Health Care
- CII Finance
- Exchange
- IMTX Nasdaq
- CII Nasdaq
- Market Cap
- IMTX 954.2M
- CII 875.1M
- IPO Year
- IMTX N/A
- CII N/A
- Fundamental
- Price
- IMTX $5.35
- CII $20.60
- Analyst Decision
- IMTX Strong Buy
- CII
- Analyst Count
- IMTX 4
- CII 0
- Target Price
- IMTX $16.67
- CII N/A
- AVG Volume (30 Days)
- IMTX 988.8K
- CII 78.8K
- Earning Date
- IMTX 11-18-2024
- CII 01-01-0001
- Dividend Yield
- IMTX N/A
- CII 6.17%
- EPS Growth
- IMTX N/A
- CII N/A
- EPS
- IMTX N/A
- CII N/A
- Revenue
- IMTX $128,824,447.00
- CII N/A
- Revenue This Year
- IMTX $116.22
- CII N/A
- Revenue Next Year
- IMTX N/A
- CII N/A
- P/E Ratio
- IMTX N/A
- CII N/A
- Revenue Growth
- IMTX 52.53
- CII N/A
- 52 Week Low
- IMTX $5.28
- CII $16.76
- 52 Week High
- IMTX $13.77
- CII $19.81
- Technical
- Relative Strength Index (RSI)
- IMTX 21.22
- CII 63.08
- Support Level
- IMTX $7.00
- CII $20.01
- Resistance Level
- IMTX $7.42
- CII $20.46
- Average True Range (ATR)
- IMTX 0.41
- CII 0.20
- MACD
- IMTX -0.14
- CII 0.02
- Stochastic Oscillator
- IMTX 2.90
- CII 86.68
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.